EBITDA for CVS Health (CVS)
According to CVS Health's latest reported financial statements, the company's current EBITDA (TTM) is $9.86B USD. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a common proxy for operating cash generation that strips out non-cash charges (depreciation and amortization) and capital structure effects (interest, taxes). Useful for comparing companies with different leverage and asset bases — see operating income and net income for fully GAAP figures.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
CVS
Currently viewingEBITDASwitch metric
TTM (last 4 quarters)
$9.86B
YoY change
-27.9%
5Y CAGR
-10.4%
Peak year (2023)
$18.20B
Cumulative EBITDA
$238.84B
EBITDA history chart for CVS Health (CVS) from 1985 to 2025
EBITDA history table for CVS Health (CVS) from 1985 to 2025
| Fiscal year | Period ended | Reported | EBITDA | YoY |
|---|---|---|---|---|
| 2025 | $9.86B | -27.9% | ||
| 2024 | $13.68B | -24.8% | ||
| 2023 | $18.20B | +47.4% | ||
| 2022 | $12.35B | -29.6% | ||
| 2021 | $17.53B | +2.4% | ||
| 2020 | $17.12B | +4.4% | ||
| 2019 | $16.40B | +143.3% | ||
| 2018 | $6.74B | -42.9% | ||
| 2017 | $11.81B | -3.1% | ||
| 2016 | $12.19B | +5.4% | ||
| 2015 | $11.57B | +13.1% | ||
| 2014 | $10.22B | +3.1% | ||
| 2013 | $9.91B | +15.0% | ||
| 2012 | $8.62B | +9.1% | ||
| 2011 | $7.90B | +3.9% | ||
| 2010 | $7.61B | -2.7% | ||
| 2009 | $7.82B | +6.5% | ||
| 2008 | $7.34B | +24.7% | ||
| 2007 | $5.89B | +85.5% | ||
| 2006 | $3.17B | +21.7% | ||
| 2005 | $2.61B | +33.7% | ||
| 2004 | $1.95B | +10.5% | ||
| 2003 | $1.77B | +16.4% | ||
| 2002 | $1.52B | +5.0% | ||
| 2001 | $1.44B | -10.8% | ||
| 2000 | $1.62B | +14.6% | ||
| 1999 | $1.41B | +19.8% | ||
| 1998 | $1.18B | +24.7% | ||
| 1997 | $946.70M | +9.1% | ||
| 1996 | $867.50M | +19.8% | ||
| 1995 | $723.90M | -11.4% | ||
| 1994 | $817.00M | +0.3% | ||
| 1993 | $814.90M | +45.0% | ||
| 1992 | $561.90M | -30.5% | ||
| 1991 | $808.10M | +3.8% | ||
| 1990 | $778.60M | +2.6% | ||
| 1989 | $758.70M | +12.9% | ||
| 1988 | $671.80M | +12.8% | ||
| 1987 | $595.60M | +8.8% | ||
| 1986 | $547.60M | +6.9% | ||
| 1985 | $512.10M | — |
EBITDA values are taken from CVS Health's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
2025's annual EBITDA for CVS Health (CVS) came in at $9.86B – declined 27.9% year-over-year.
CVS Health EBITDA compound annual growth for the 2020–2025 (5 years) window is -10.4%, with a net decline across the window.
Between 2023 and 2025, CVS Health EBITDA plunged 45.8%, falling from $18.20B to $9.86B.
The highest annual EBITDA of $18.20B was reported in 2023. The lowest in the available history was $512.10M in 1985.
Within Healthcare, CVS Health (CVS) ranks 9th among 8 peers we track. The peer median for EBITDA is $24.21B.
CVS Health EBITDA by Year
CVS Health EBITDA 2025: $9.86B
CVS Health EBITDA in 2025 was $9.86B, declined 27.9% below 2024.
CVS Health EBITDA 2024: $13.68B
CVS Health EBITDA in 2024 was $13.68B, declined 24.8% below 2023.
CVS Health EBITDA 2023: $18.20B
CVS Health EBITDA in 2023 was $18.20B, surged 47.4% from 2022. This figure represents the highest annual value in the available history.
CVS Health EBITDA 2022: $12.35B
CVS Health EBITDA in 2022 was $12.35B, declined 29.6% below 2021.
CVS Health EBITDA 2021: $17.53B
CVS Health EBITDA in 2021 was $17.53B.
See more financial history for CVS Health (CVS).
Sector peers — EBITDA
Companies in the same sector as CVS Health, ranked by their latest EBITDA.
| Company | EBITDA | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $156.73B | Healthcare |
| Johnson & Johnson (JNJ) | $41.05B | Healthcare |
| Eli Lilly and Company (LLY) | $27.94B | Healthcare |
| Merck & Co., Inc. (MRK) | $25.36B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $23.06B | Healthcare |
| AstraZeneca PLC (AZN) | $19.83B | Healthcare |
| AbbVie Inc. (ABBV) | $17.63B | Healthcare |
| Amgen Inc. (AMGN) | $15.84B | Healthcare |
Frequently asked questions
What is CVS Health's EBITDA?
- Latest reported EBITDA for CVS Health (CVS) is $9.86B (period ending December 31, 2025).
How has CVS Health EBITDA changed year-over-year?
- CVS Health (CVS) EBITDA changed -27.9% year-over-year on the latest annual filing.
What is the long-term growth rate of CVS Health EBITDA?
- CVS Health (CVS) EBITDA compound annual growth rate is -10.4% over the most recent 5 years available.
When did CVS Health EBITDA hit its highest annual value?
- CVS Health EBITDA reached its highest annual value of $18.20B in 2023.
What was CVS Health EBITDA in 2024?
- CVS Health (CVS) EBITDA in 2024 was $13.68B.
What was CVS Health EBITDA in 2025?
- CVS Health (CVS) EBITDA in 2025 was $9.86B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
CVS Overview
Company profile, financial tools, and key metrics
CVS Revenue Counter
Earns $12,749 every second. See per minute, hour, and day.
CVS Earnings Counter
Earns $56.06 per second net profit. See per minute, hour, and day.
CVS Economic Scale
Exceeds South Africa's GDP. Compare with world economies.
CVS What If Invested
What if you had invested $1,000? See historical returns from any date.
CVS How It Makes Money
Discover visual breakdown of $402.07B in revenue — where it comes from and where it goes.
CVS Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
CVS Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
CVS Daily Price Character
Steady · 50.0% historical win rate (green days). Streaks & record days.
CVS Buybacks
Recent repurchase activity. Shareholder yield & SBC comparison.
CVS Stock Split History
4 splits on record. Dates, ratios, and cumulative multiple.
CVS Dividend Profile
Yield: 3.18%. Safety: 4/8. See full history.
CVS Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
CVS Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.